每年研究成果
研究成果 2009 2020
2019
Central nervous system toxoplasmosis in an immunocompetent individual
Chang, H. J., Hong, C. T., Hu, C. J. & Chan, L., 一月 1 2019, 於 : Kaohsiung Journal of Medical Sciences.研究成果: 雜誌貢獻 › 快報
開啟存取
Cerebral Toxoplasmosis
2014
Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses"
Chao, A. C., Po, H. L. & Chan, L., 一月 1 2014, 於 : Stroke. 45, 12研究成果: 雜誌貢獻 › 快報
2010
1
引文
(Scopus)
Delay in seeking treatment is still the main barrier in receiving acute stroke therapy
Chan, L., 八月 1 2010, 於 : Stroke. 41, 8研究成果: 雜誌貢獻 › 快報
Health Services Accessibility
Fibrinolytic Agents
Tissue Plasminogen Activator
Taiwan
Stroke
1
引文
(Scopus)
Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?
Chan, L., 一月 1 2010, 於 : Archives of Neurology. 67, 9, 1 p.研究成果: 雜誌貢獻 › 快報
Cerebral Hemorrhage
Tissue Plasminogen Activator
Stroke
Dabigatran